Age, 18–85 years |
Failure of PCI or need for CABG |
Weight, 45–110 kg |
Cardiogenic shock of other origin than ischemic (e.g., tamponade, valvular disease, arrhythmogenic) |
Height, 150–195 cm |
Instability necessitating significant change of conditions (e.g., catecholamine dose, ventilation) before pyruvate infusion |
Acute myocardial infarction |
Failure to insert intra-aortic balloon pump |
Successful primary PCI |
Malignant tumor |
Cardiogenic shock |
Pregnancy or lactation |
Need for catecholamines or intra-aortic balloon pump |
Poor compliance |
Stable conditions in hemodynamics, rhythm and ventilation before pyruvate infusion |
Alcohol or drug abuse |
|
Participation in concurrent clinical trial |